Date: 2014-12-17 12:04:58

Health

Food and Drug Administration

Clinical pharmacology

Therapeutics

United States Public Health Service

KV Pharmaceutical

17-Hydroxyprogesterone caproate

Compounding

FDA Warning Letter

Pharmacology

Pharmaceutical sciences

Clinical research

USCA Case #[removed]Document #[removed]Filed: [removed]

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 126,34 KB